Clinical effectiveness and bacteriological eradication of three different Short-COurse antibiotic regimens and single-dose fosfomycin for uncomplicated lower Urinary Tract infections in adult women (SCOUT study): study protocol for a randomised clinical trial

Abstract

IntroductionUncomplicated lower urinary tract infections (uLUTI) are a common problem in primary care. Current local guidelines recommend the use of a single 3 g dose of fosfomycin. However, most general practitioners (GP) prefer short-course therapies to single-dose therapy. No study has compared head-to-head short-course antimicrobial agents for uLUTIs. Therefore, the aim of this randomised clinical trial is to compare three different short-course antibiotic therapies with a single-dose of fosfomycin for these infections.Methods and analysisThis will be a pragmatic, multicentre, parallel group, open trial. Women aged 18 or older and with symptoms of uLUTI and a positive urine dipstick analysis will be randomised to one of the following four groups: a single dose of 3 g of fosfomycin, 2 days of 3 g of fosfomycin o.d., 3 days of pivmecillinam 400 mg three times per day (t.i.d) or 5 days of nitrofurantoin 100 mg t.i.d. A total sample of 1120 patients was calculated. The primary endpoint is clinical effectiveness at day 7, defined as cure of symptoms reported by the patients in a diary including four symptoms: dysuria, urgency, frequency and suprapubic pain, which will be scored on a 4-point severity scale (not present/mild/moderate/severe). Follow-up visits are scheduled at days 7 (phone call), 14 and 28 for assessing evolution. Urine samples will be collected in the three on-site visits and urine cultures performed. If positive, antibiograms for the three antibiotics studied will be performed. Bacterial eradication will be measured at days 14 and 28.Ethics and disseminationThe study was approved by the Ethical Board of IDIAP Jordi Gol (reference number: 21/173-AC) and Spanish Agency of Medicines and Medical Devices. The findings of this trial will be disseminated through research conferences and peer-review journals.Trial registration numberNCT04959331; EudraCT Number: 2021-001332-26.Time scheduleJanuary 2022 to April 2023.

Bacteriological Investigation of Pathogenic Bacteria Causing Urinary Tract Infections: A cross-Sectional Study

“…It often feels like a urinary tract infection but is not always one. These symptoms can be caused by a wide range of other things, including kidney stones, an enlarged prostate or medication [20]. In this study, there were 27 men and 75 women were infected with UTIs.…”

An Investigation of Bacterial Infections in the Urinary Tract of Babylon City Women in Iraq, a Cross-Sectional Study

“…Women are twice as likely to develop a UTI as men [14]. Women who have already had a UTI are twice as likely to have another in the future, and most UTIs recur within 6 months of the initial infection [15]. If a UTI does not clear within 7 days, it is considered to be a repeat infection and requires different management.…”

Bacteriological and Immunological study of kidney failure patients infected with urinary tract infections

“…Prompt management and appropriate treatment are crucial to prevent complications and ensure a swift recovery. Urinary tract infections (UTIs) are a common medical condition characterized by the presence of pathogenic microorganisms in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra [21]. The symptoms of UTIs often include frequent urination, a burning sensation during urination, and lower abdominal pain; if left untreated, these infections can lead to severe complications, such as kidney damage and sepsis, ultimately posing a significant threat to an individual's overall health and well-being [22].…”